Comparative study of analgesic effect of intrathecal nalbuphine and tramadol in patients undergoing vaginal hysterectomy
Aims: To compare the analgesic effect and block characteristics of intrathecal nalbuphine and tramadol in patients undergoing vaginal hysterectomy.
Settings and design: Prospective, double-blind, randomized study on 80 patients of age 20-60 years, undergoing vaginal hysterectomy under spinal anaesthesia.
Methods and Material: Random allocation in two groups, where group T and group N received 25 mg tramdol and 1 mg nalbuphine respectively along with 15 mg 0.5% hyperbaric bupivacine through intrathecal route. Drugs were administered at the L3-4 interspace with the patient in the sitting position. Spinal block was assessed by pin prick and modified bromage scale. In postoperative period time of first request of analgesia, number of rescue analgesia, the duration of motor block from the time of drug administration to the time when patient was able to lift his leg and the adverse effects were recorded. Quantitative variables were compared using Unpaired t-test/Mann-Whitney Test. Qualitative variables were correlated using Chi-Square test /Fisher’s exact test. A p value of <0.05 was considered statistically significant.
Results: group N achieved faster onset of sensory block than group T (Group N=2.74±0.46min, Group T= 3.9±0.37min) (p<.0001) Time to reach peak sensory level was lesser in nalbuphine group than tramadol group. (Group T= 8.65 ± 0.86 min, Group N=7.42 ± 0.92min) (p<.0001). Mean peak sensory level was statistically comparable in both groups (Group T= T6.5±0.89, Group N=T6.1±0.53) (p>0.05).
Conclusion: In terms of sensory and motor block characteristics, nalbuphine provides faster onset, faster peak of analgesia than tramadol. In terms of postoperative analgesia nalbuphine and tramadol were statistically similar.
Key message: This study establishes the efficacy of Nalbuphine (1mg) as an intrathecal adjuvant to 15 mg of 0.5% hyperbaric bupivacaine for enhancing the intraoperative sensory block and better haemodynamic stability than Tramadol (25 mg) as an intrathecal adjuvant. In terms of postoperative analgesia and motor block characteristics both the drugs are comparable.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).